Want to join the conversation?
$CW reaffirmed its 2016 operating margin outlook of 14.2-14.4% and its EPS guidance of $4.00-4.15. Also, the company maintained its 2016 free cash flow generation estimate of $300-320MM. $CW expects modest, sequential improvement in 3Q16 EPS of $0.95-1.00, followed by a strong 4Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?